EZH2 also aids tumors in co-opting immune suppression via cytokine networks; a recent study in HCC demonstrated that EZH2, through cooperation with NF-κB, upregulates IL-6, driving MDSC accumulation and T-cell suppression 65. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.